BioSpace News Archive

Biotech Bay

IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi

IGM Biosciences, Inc. announced that the Company will host a conference call and live audio webcast, Tuesday, March 29, 2022, at 8:00 am ET to discuss the Company’s global collaboration agreement with Sanofi, as recently announced.

March 29, 2022
·
1 min read
Miracor Medical starts 2nd randomized study, targeting expanded indications. 300 patients have been treated with PiCSO®

Miracor Medical SA announced the first patient enrolled in the PICSO-AMI-V study to evaluate the benefits of PiCSO® therapy as an adjunct to conventional primary percutaneous coronary intervention for patients presenting with inferior ST-Elevation Myocardial Infarction.

March 29, 2022
·
5 min read
Angle PLC Announces Rapid Information on Patient Response to Therapies

ANGLE plc is pleased to announce that the University of Maryland Marlene and Stewart Greenebaum NCI Comprehensive Cancer Institute, Baltimore, Maryland, USA, has published results of work undertaken in preclinical models of triple-negative breast cancer.

March 29, 2022
·
7 min read
XNK Therapeutics raises SEK 132 million to accelerate growth

XNK Therapeutics AB announced it has secured a private placement of SEK 132 million, to existing and new investors, led by Flerie Invest AB.

March 29, 2022
·
3 min read
IAMA Therapeutics Partners with the Italian Institute of Technology to Embark on Landmark Research on Neuroscience Drug Discovery

IAMA Therapeutics announced a strategic collaboration with the IIT-Istituto Italiano di Tecnologia - where they will design and profile new classes of compounds targeting cation cotransporters in the CNS area.

March 29, 2022
·
3 min read
Business

Vincerx Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update

Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported financial results for the fourth quarter and full year ended December 31, 2021, and provided a corporate update.

March 29, 2022
·
11 min read
Business

Candel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Highlights

Candel Therapeutics, Inc., a late clinical stage biopharmaceutical company focused on helping patients fight cancer with oncolytic viral immunotherapies, reported financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update.

March 29, 2022
·
11 min read
Genetown

T2 Biosystems to Host Analyst and Investor Day on April 12, 2022

T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced that it will host an Analyst and Investor Day on Tuesday, April 12, 2022, at 12:00pm ET.

March 29, 2022
·
1 min read
Business

Nkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors

Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced the appointment of Angela M. Thedinga, MBA, MPH, to its Board of Directors.

March 29, 2022
·
4 min read
Business

Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the year ended December 31, 2021.

March 29, 2022
·
19 min read